Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,887,242
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1,815,508
-
Shares change
-
-33,675
-
Total reported value, excl. options
-
$3,072,270
-
Value change
-
-$77,601
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$1.69
Significant Holders of Aprea Therapeutics, Inc. - Common Stock (APRE) as of Q2 2025
26 filings reported holding APRE - Aprea Therapeutics, Inc. - Common Stock as of Q2 2025.
Aprea Therapeutics, Inc. - Common Stock (APRE) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,815,508 shares
of 6,887,242 outstanding shares and own 26% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (539,300 shares), Sio Capital Management, LLC (279,369 shares), SPHERA FUNDS MANAGEMENT LTD. (270,000 shares), Nantahala Capital Management, LLC (205,760 shares), VANGUARD GROUP INC (173,842 shares), DAFNA Capital Management LLC (137,174 shares), MORGAN STANLEY (63,331 shares), GEODE CAPITAL MANAGEMENT, LLC (43,137 shares), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (23,969 shares), and LPL Financial LLC (17,052 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.